Explore the words cloud of the iPLACENTA project. It provides you a very rough idea of what is the project "iPLACENTA" about.
The following table provides information about the project.
Coordinator |
UNIVERSITY OF DUNDEE
Organization address contact info |
Coordinator Country | United Kingdom [UK] |
Total cost | 3˙929˙698 € |
EC max contribution | 3˙929˙698 € (100%) |
Programme |
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers) |
Code Call | H2020-MSCA-ITN-2017 |
Funding Scheme | MSCA-ITN-ETN |
Starting year | 2018 |
Duration (year-month-day) | from 2018-01-01 to 2021-12-31 |
Take a look of project's partnership.
“The placenta is the least understood human organ but arguably one of the most important”-NIH Human Placenta Project . Innovation in Modelling Placenta for Maternal and Fetal Health (iPLACENTA) is a European Training Network (ETN), and will act as a springboard for promoting international, intersectoral and multi/inter-disciplinary training, career development and collaboration of fifteen early-stage researchers (ESRs) in Maternal and Fetal Health. iPLACENTA will improve our ability to study, model and visualise the placenta. iPLACENTA focuses on doctoral-level training and will be delivered by eleven participating universities located in ten different European countries. It coordinates research and training collaboration among world-leading academic institutions in Europe, providing a new combination of in-depth international expertise. iPLACENTA’s unique network aims are to improve our ability to study the placenta through in vitro and mathematical modelling (WP1&2). Whilst enhancing visualisation and assessment of the placenta in animal models and the clinic, thus enhancing investigation and prognosis of complicated pregnancies. To link the research to industrial exploitation, the network brings together four different businesses; two established companies as beneficiaries Mimetas (MIM) (organ-on-a-chip developer) and Moor, a clinical-technology specialist, together with two partners that are industrial global brands Samsung (SAM) and FujifFilm VisualSonics (FUJ). Together they will work with academics and clinicians to develop new placenta-on-a-chip technology (WP1), in silico placenta modelling (WP2), new modalities of laser technology to visualise the placenta in vivo (WP3), improve maternal-cardiovascular assessment and validate novel ultrasound tools for diagnosis of complicated pregnancies (WP3). Cross-sectorial training delivered by Business and Law Schools, Industry, Clinical specialist and European leaders in OpenScience-OpenInnovation.
year | authors and title | journal | last update |
---|---|---|---|
2020 |
Karen Melchiorre, Basky Thilaganathan, Veronica Giorgione, Anna Ridder, Alessia Memmo, Asma Khalil Hypertensive Disorders of Pregnancy and Future Cardiovascular Health published pages: , ISSN: 2297-055X, DOI: 10.3389/fcvm.2020.00059 |
Frontiers in Cardiovascular Medicine 7 | 2020-04-24 |
2020 |
Soragni C, Rabussier G, Lanz HL, de Windt LJ, Trietsch SJ, Ng CP Barrier integrity of HUVEC cultured in 3-lane Organoplate® with low level of oxygen published pages: , ISSN: , DOI: |
International Cell Culture Under Flow Meeting 2020, Abstract Book 2020 | 2020-03-05 |
2019 |
​Loscalzo G, Moralles-Roselló J, GarcÃa Gimenez JL, Martinez Priego L, González-RodrÃguez D, Mena Mollá S, Maquieira Catalá A, Buongiorno S, Cañada MartÃnez AJ, Perales MarÃn A ​MicroRNA-148B-3P and MicroRNA-25-3P are overexpressed in fetuses with late-onset fetal growth restriction published pages: Abstract 28, ISSN: , DOI: |
8th International Conference on Fetal Growth 2019 | 2019-11-28 |
2019 |
Lermant, Murdoch Cysteine Glutathionylation Acts as a Redox Switch in Endothelial Cells published pages: 315, ISSN: 2076-3921, DOI: 10.3390/antiox8080315 |
Antioxidants 8/8 | 2019-08-29 |
2019 |
Anna Ridder, Veronica Giorgione, Asma Khalil, Basky Thilaganathan Preeclampsia: The Relationship between Uterine Artery Blood Flow and Trophoblast Function published pages: 3263, ISSN: 1422-0067, DOI: 10.3390/ijms20133263 |
International Journal of Molecular Sciences 20/13 | 2019-09-02 |
2019 |
Clara Apicella, Camino S. M. Ruano, Céline Méhats, Francisco Miralles, Daniel Vaiman The Role of Epigenetics in Placental Development and the Etiology of Preeclampsia published pages: 2837, ISSN: 1422-0067, DOI: 10.3390/ijms20112837 |
International Journal of Molecular Sciences 20/11 | 2019-09-02 |
2019 |
Samprikta Manna, Cathal McCarthy, Fergus P. McCarthy Placental Ageing in Adverse Pregnancy Outcomes: Telomere Shortening, Cell Senescence, and Mitochondrial Dysfunction published pages: 1-11, ISSN: 1942-0900, DOI: 10.1155/2019/3095383 |
Oxidative Medicine and Cellular Longevity 2019 | 2019-07-08 |
2019 |
Basky Thilaganathan, Erkan Kalafat Cardiovascular System in Preeclampsia and Beyond published pages: 522-531, ISSN: 0194-911X, DOI: 10.1161/hypertensionaha.118.11191 |
Hypertension 73/3 | 2019-08-05 |
2018 |
Dongqing Guo, Colin E. Murdoch, Tianhua Liu, Jia Qu, Shihong Jiao, Yong Wang, Wei Wang, Xing Chen Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review published pages: , ISSN: 1663-9812, DOI: 10.3389/fphar.2018.00428 |
Frontiers in Pharmacology 9 | 2019-07-08 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IPLACENTA" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "IPLACENTA" are provided by the European Opendata Portal: CORDIS opendata.